Eli Lilly recently announced that by July 1, 2026, Medicare beneficiaries in the United States will be able to access the company's discounted obesity treatment drugs.

老虎证券2026/02/12 19:44

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

The announcement of this timeline highlights Eli Lilly's active progress in expanding the accessibility of its weight loss medication. The company is working with relevant medical insurance institutions to enable eligible patient groups to benefit from its innovative therapy as soon as possible. This move is expected not only to alleviate the medical burden on patients with obesity, but also reflects the trend of pharmaceutical companies collaborating with public health insurance systems to promote the widespread availability of important drugs. As a key component of Eli Lilly's product line, the inclusion of its weight loss medication in insurance coverage will further enhance the market penetration of this drug.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Jensen Huang has recently made consecutive public statements claiming that AI development does not require new laws or regulations, characterizing the opposition between innovation and safety as a "false choice." He publicly appeared with Trump, forming a stark contrast to the stance of Dario Amodei, Sam Altman, and Elon Musk, who have called for coordinated efforts to slow down AI research. However, Nvidia’s business interests are closely tied to the pace of investment in AI infrastructure.

华尔街见闻•2026/09/16 00:21